Home » Tenders » Americas » USA » Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related... Tender

Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias... Tender

Download Documents

NATIONAL INSTITUTES OF HEALTH has floated a tender for Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional). The project location is USA and the tender is closing on 07 Jan 2025. The tender notice number is PAR-21-360, while the TOT Ref Number is 62037435. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)

Deadline : 07 Jan 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 62037435

Document Ref. No. : PAR-21-360

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Tender are invited for Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)

CFDA Number : 93.866 -- Aging Research

Cost Sharing or Matching Requirement : No

Closing Date for Applications: Jan 07, 2025

Posted Date : Jan 10, 2022

Description: The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods.

Documents

Tender Notice

Browse More

All Tenders From USA

All Tenders From Americas

Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services

View Tenders By

Publish Tenders

Superior Approach, High ROI

Instantneous Global Reach